MedTrace Logo

Acceptance and Performance of CP1110 Sound Processor With Experienced Adult Cochlear Implant Recipients.

NCT05080283 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2025-03-25

Study results available
· View outcomes & findings →

Summary

The clinical study aims to investigate acceptance, actual-use usability and speech performance with a new behind-the-ear sound processor (model number: CP1110) system, compared with the commercially available Nucleus 7 Sound Processor (model: CP1000) system, with particular focus on the acceptance of and satisfaction with a noise reduction feature in the Automatic Scene Classifier 'SCAN 2'.

Conditions

  • Adult Cochlear Implant Recipients

Interventions

DEVICE

CP1110 Sound Processor System with automated ForwardFocus On (SCAN 2 FF)

Sound Processor

DEVICE

Nucleus 7 Sound Processor (model: CP1000) system

Sound Processor

DEVICE

CP1110 Sound Processor System with ForwardFocus Off (SCAN 2)

Sound Processor

Sponsors & Collaborators

  • Avania

    collaborator INDUSTRY

  • Cochlear

    lead INDUSTRY

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-11-02
Primary Completion
2022-09-13
Completion
2022-09-13

Countries

  • Australia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05080283 on ClinicalTrials.gov